Bausch + lomb receives health canada approval for envista® envy™* full visual range intraocular lens

Vaughan, ontario--(business wire)--bausch + lomb corporation (nyse/tsx: blco), a leading global eye health company dedicated to helping people see better to live better, today announced that health canada has approved the envista® envy™* full visual range intraocular lens (iol). this is the first global regulatory approval of the new lens, which offers a full range of vision with excellent dysphotopsia tolerance on the widely used envista iol platform. “envista envy is the next step in the dram.
BLCO Ratings Summary
BLCO Quant Ranking